The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US8618286, 3 ID: ALA3675231
PubChem CID: 44599933
Max Phase: Preclinical
Molecular Formula: C19H22N4O2S
Molecular Weight: 370.48
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: N/C(=N\c1ccc2c(c1)OCC(=O)N2CCN1CCCC1)c1cccs1
Standard InChI: InChI=1S/C19H22N4O2S/c20-19(17-4-3-11-26-17)21-14-5-6-15-16(12-14)25-13-18(24)23(15)10-9-22-7-1-2-8-22/h3-6,11-12H,1-2,7-10,13H2,(H2,20,21)
Standard InChI Key: LFKLDLHIJLFFAI-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
1.5548 -3.6021 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5951 -3.0039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5973 -1.5031 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 1.5000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.6012 3.0008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9020 3.7494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9051 5.2502 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.1186 6.1100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6551 7.5366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1551 7.5366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6916 6.1100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8971 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9364 1.3500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.8971 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 -1.5000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8933 -3.7570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0312 -5.2378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4984 -5.5497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2484 -4.2507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2447 -3.1359 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 11 1 0
8 16 1 0
16 17 2 0
16 18 1 0
18 19 1 0
19 20 1 0
20 7 1 0
20 21 2 0
21 4 1 0
2 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 22 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 370.48Molecular Weight (Monoisotopic): 370.1463AlogP: 2.61#Rotatable Bonds: 5Polar Surface Area: 71.16Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.97CX LogP: 1.93CX LogD: 1.18Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.65Np Likeness Score: -1.83
References 1. (2013) Benzoxazines, benzothiazines, and related compounds having NOS inhibitory activity,